Valproic acid poisoning: An evidence-based consensus guideline for out-of-hospital management

Clinical Toxicology

Volumn 46, Issue 7, 2008, Pages 661-676

  Manoguerra, Anthony S ^a   Erdman, Andrew R ^a   Woolf, Alan D ^a   Chyka, Peter A ^a   Martin Caravati, E ^a   Scharman, Elizabeth J ^a   Booze, Lisa L ^a   Christianson, Gwenn ^a   Nelson, Lewis S ^a   Cobaugh, Daniel J ^a   Troutman, William G ^a  

^a American Association of Poison Control Centers   (United States)

Author keywords

Poison control centers standards; Practice guidelines; Valproic acid poisoning

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; ALCOHOL; BENZODIAZEPINE; CARNITINE; CHLORPHENIRAMINE; CLONAZEPAM; IPECAC; NALOXONE; OPIATE; PAROXETINE; SODIUM BROMIDE; VALPROATE SEMISODIUM; VALPROIC ACID; VALPROMIDE;

AGE DISTRIBUTION; BRAIN EDEMA; CAREGIVER; CHILD ABUSE; CHILD NEGLECT; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMA; CONSENSUS DEVELOPMENT; CONTINUOUS INFUSION; CONTROLLED DRUG RELEASE; CONVULSION; COST CONTROL; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSAGE FORM; DRUG FATALITY; DRUG FORMULATION; DRUG INTOXICATION; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FETUS RISK; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LIVER FAILURE; LIVER TOXICITY; MATERNAL CARE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; NEUROTOXICITY; OUTPATIENT CARE; PATIENT CARE; PATIENT REFERRAL; POISON CENTER; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; RESPIRATION DEPRESSION; REVIEW; SEIZURE; SOMNOLENCE; STOMACH LAVAGE; SUICIDE; UNITED STATES; VOMITING;

AMBULATORY CARE; ANTIDOTES; CHARCOAL; HUMANS; OVERDOSE; POISON CONTROL CENTERS; POISONING; PRACTICE GUIDELINES AS TOPIC; VALPROIC ACID;

EID: 48349083053     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650802178136     Document Type: Review

References (85)

1. Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, Flanagan A, Wruk KM. 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666.
2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2006. URL: http://www.clinicalpharmacology.com. Accessed April 2006.
3. Drugdex system [Internet database]. Greenwood Village, CO: Thomson Micromedex. Updated periodically. Accessed April 2006.
4. McNamara JO. In Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 11th edition. New York: McGraw Hill: 2006. 501-525.
5. Depakene Product Label: Drugs@FDA website: http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/. Accessed April 2006.
6. Depakote Product Label. Drugs@FDA website: http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/. Accessed April 2006.
7. Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D. Central nervous system manifestations of a valproic acid overdose responsive to naloxone. Ann Emerg Med 1989; 18:889-891.
8. Espinoza O, Maradei I, Ramirez M, Pascuzzo-Lima C. An unusual presentation of opioid-like syndrome in pediatric valproic acid poisoning. Vet Hum Toxicol 2001; 43:178-179.
9. Farrar HC, Herold DA, Reed MD. Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal. Crit Care Med 1993; 21:299-301.
10. Connacher AA, Macnab MS, Moody JP, Jung RT. Fatality due to massive overdose of sodium valproate. Scott Med J 1987; 32:85-86.
11. Eeg-Olofsson O, Lindskog U. Acute intoxication with valproate. Lancet 1982; 1:1306.
12. Franssen EJ, van Essen GG, Portman AT, de Jong J, Go G, Stegeman CA, Uges DR. Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 1999; 21:289-292.
13. Isbister GK, Balit CR, Whyte IM, Dawson A. Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol 2003; 55:398-404.
14. Lynch A, Tobias JD. Acute valproate ingestion induces symptomatic methemoglobinemia. Pediatr Emerg Care 1998; 14:205-207.
15. Roodhooft AM, Van Dam K, Haentjens D, Verpooten GA, Van Acker KJ. Acute sodium valproate intoxication: occurrence of renal failure and treatment with haemoperfusion-haemodialysis. Eur J Pediatr 1990; 149:363-364.
16. Singh SM, McCormick BB, Mustata S, Thompson M, Prasad GV. Extracorporeal management of valproic acid overdose: a large regional experience. J Nephrol 2004; 17:43-49.
17. Doyon S. Anticonvulsants. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA and Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th edition. New York: McGraw Hill; 2006: 737-739.
18. Snodgrass WR. In: Brent J, Phillips SD, Wallace KL, Donovan JW, Burkhart KK, eds. Critical Care Toxicology. Diagnosis and Management of the Critically Poisoned Patient. Philadelphia: Elsevier Mosby; 2005: 565-570.
19. Mortensen PB, Hansen HE, Pedersen B, Hartmann-Andersen F, Husted SE. Acute valproate intoxication: biochemical investigations and hemodialysis treatment. Int J Clin Pharmacol Ther Toxicol 1983; 21:64-68.
20. Murakami K, Sugimoto T, Woo M, Nishida N, Muro H. Effect of L-carnitine supplementation on acute valproate intoxication. Epilepsia 1996; 37:687-689.
21. Siemes H, Nau H, Schultze K, Wittfoht W, Drews E, Penzien J, Seidel U. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia 1993; 34:332-346.
22. Bryant AE 3rd, Dreifuss FE. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 1996; 46:465-469.
23. Eyer F, Felgenhauer N, Gempel K, Steimer W, Gerbitz KD, Zilker T. Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy. J Clin Psychopharmacol 2005; 25:376-380.
24. Pinkston R, Walker LA. Multiorgan system failure caused by valproic acid toxicity. Am J Emerg Med 1997; 15:504-506.
25. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999; 281:1900-1905.
26. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med 2003; 139:493-498.
27. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States. Advance data from vital and health statistics; no. 314. Hyattsville, MD; National Center for Health Statistics, 2004. available at: http://www.cdc.gov/nchs/data/ad/ ad314.pdf. Accessed April 2006.
28. Normann SA, Speranza VC, Gaar GG. Valproate and selected newer anticonvulsants. In: Ford MD, Delaney KA. Ling J, Erickson T. Clinical Toxicology. Philadelphia: WB Saunders, 2001.
29. Seger D. Anticonvulsants. In: Haddad LM, Shannon MW, Winchester JF, eds. Clinical Management of Poisoning and Drug Overdose. 3rd ed. Philadelphia: WB Saunders, 1998.
30. Seger D. Anticonvulsant medications. In: Dart RC, ed. Medical Toxicology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins, 2004.
31. Barrueto F, Nelson LS. Antiepileptic agents. In: Erickson TR, Ahrens WR, Aks SE, Baum CR, Ling LJ, eds. Pediatric Toxicology: Diagnosis & Management of the Poisoned Child. New York: McGraw-Hill, 2005.
32. Valproic acid management in: Klasco RK, ed. Poisindex system. Greenwood Village (CO): Thomson Micromedex; edition expires March 2006.
33. Garnier R, Fournier E. Intoxication aiguë par le valproate de sodium. Nouv Presse Med 1982; 11:678.
34. von Bardeleben RS, Stürer A, Weilemann LS. Valproic acid intoxications in 96 documented cases 1995-1998: the role of hemoperfusion in therapy [abstract]. J Toxicol Clin Toxicol 1998; 36:471-472.
35. Dharnidharka VR, Fennell RS, 3rd, Richard GA. Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol 2002; 17:312-315.
36. Dupuis RE, Lichtman SN, Pollack GM. Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites. Drug Saf 1990; 5:65-71.
37. Ishikura H, Matsuo N, Matsubara M, Ishihara T, Takeyama N, Tanaka T. Valproic acid overdose and L-carnitine therapy. J Anal Toxicol 1996; 20:55-58.
38. Janssen F, Rambeck B, Schnabel R. Acute valproate intoxication with fatal outcome in an infant. Neuropediatrics 1985; 16:235-238.
39. Manabe Y, Uriu M, Kanamori Y, Furukawa F. Acute valproate intoxication. Pharm Mon 1987; 29:657-659.
40. Steiman GS, Woerpel RW, Sherard ES Jr. Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol 1979; 6:274.
41. Lifshitz M, Gavrilov V. Acute valproic acid poisoning in young children. J Pharm Technol 2001; 17:151-153.
42. al-Shareef A, Buss DC, Shetty HG, Ali N, Routledge PA. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers. Br J Clin Pharmacol 1997; 43:109-111.
43. Al Aly Z, Yalamanchili P, Gonzalez E. Extracorporeal management of valproic acid toxicity: a case report and review of the literature. Semin Dialysis 2005; 18:62-66.
44. Andersen GO, Ritland S. Life threatening intoxication with sodium valproate. J Toxicol Clin Toxicol 1995; 33:279-284.
45. Azaroual N, Imbenotte M, Cartigny B, Leclerc F, Vallee L, Lhermitte M, Vermeersch G. Valproic acid intoxication identified by 1H and 1H-(13)C correlated NMR spectroscopy of urine samples. MAGMA 2000; 10:177-182.
46. Blayac D, Roch A, Michelet P, De Francheschi E, Auffray JP. Acidose lactique majeure secondaire à une intoxication volontaire par valproate. Ann Fr Anesth Reanim 2004; 23:1007-1010.
47. Camilleri C, Albertson T, Offerman S. Fatal cerebral edema after moderate valproic acid overdose. Ann Emerg Med 2005; 45:337-338.
48. Fernandez MC, Walter FG, Kloster JC, Do SM, Brady LA, Villarin A, Ruffenach SJ, Prosnitz EH, Salmon JV. Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning. Vet Hum Toxicol 1996; 38:438-443.
49. Frifelt JJ, Wanscher MC, Wienholtz G, Horwitz N, Brockhattingen A. Akut valproatforgiftning. Ugeskr Laeger 1987; 149:3255-3257.
50. Graudins A, Aaron CK. Delayed peak serum valproic acid in massive divalproex overdose - treatment with charcoal hemoperfusion. J Toxicol Clin Toxicol 1996; 34:335-341.
51. Guillaume CP, Stolk L, Dejagere TF, Kooman JP. Successful use of hemodialysis in acute valproic acid intoxication. J Toxicol Clin Toxicol 2004; 42:335-336.
52. Johnson LZ, Martinez I, Fernandez MC, Davis CP, Kasinath BS. Successful treatment of valproic acid overdose with hemodialysis. Am J Kidney Dis 1999; 33:786-789.
53. Karlsen RL, Kett K, Henriksen O. Intoxication with sodium valproate. A case report. Acta Med Scand 1983; 213:405-406.
54. Kay TD, Playford HR, Johnson DW. Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose. Clin Nephrol 2003; 59:56-58.
55. Khoo SH, Leyland MJ. Cerebral edema following acute sodium valproate overdose. J Toxicol Clin Toxicol 1992; 30:209-214.
56. Kielstein JT, Woywodt A, Schumann G, Haller H, Fliser D. Efficiency of high-flux hemodialysis in the treatment of valproic acid intoxication. J Toxicol Clin Toxicol 2003; 41:873-876.
57. Kroll P, Nand C. Hemodialysis in the treatment of valproic acid overdose. J Clin Psychiatry 2002; 63:78-79.
58. Lakhani M, McMurdo ME. Survival after severe self poisoning with sodium valproate. Postgrad Med J 1986; 62:409-410.
59. Lee WL, Yang CC, Deng JF, Chen YF, Lin HD, Wang PH. A case of severe hyperammonemia and unconsciousness following sodium valproate intoxication. Vet Hum Toxicol 1998; 40:346-348.
60. Lokan RJ, Dinan AC. An apparent fatal valproic acid poisoning. J Anal Toxicol 1988; 12:35-37.
61. Matsumoto J, Ogawa H, Maeyama R, Okudaira K, Shinka T, Kuhara T, Matsumoto I. Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Epilepsia 1997; 38:950-953.
62. Meyer S, Kuhlmann MK, Peters FT, Limbach HG, Lindinger A. Severe valproic acid intoxication is associated with atrial tachycardia: secondary detoxication by hemoperfusion. Klin Padiatr 2005; 217:82-85.
63. Minari M, Maggiore U, Tagliavini D, Rotelli C, Cabassi A, David S, Fiaccadori E. Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion. Ann Emerg Med 2002; 39:204-205.
64. Minville V, Roche Tissot C, Samii K. Epuration extrarénale, supplémentation en L carnitine et intoxication à l'acide valproïque. Ann Fr Anesth Reanim 2004; 23:357-360.
65. Montero FJ. Naloxone in the reversal of coma induced by sodium valproate. Ann Emerg Med 1999; 33:357-358.
66. Payen C, Frantz P, Martin O, Parant F, Moulsma M, Pulce C, Descotes J. Delayed toxicity following acute ingestion of valpromide. Hum Exp Toxicol 2004; 23:145-148.
67. Poklis A, Poklis JL, Trautman D, Treece C, Backer R, Harvey CM. Disposition of valproic acid in a case of fatal intoxication. J Anal Toxicol 1998; 22:537-540.
68. Robinson P, Abbott C. Severe hypothermia in association with sodium valproate overdose. N Z Med J 2005; 118:U1681.
69. Thabet H, Brahmi N, Amamou M, Ben Salah N, Hedhili A. Hyperlactatemia and hyperammonemia as secondary effects of valproic acid poisoning. Am J Emerg Med 2000; 18:508.
70. van Kuelen JG, van Wijk JA, Touw DJ, van der Deure J, Markhorst DG, Gemke RJ. Effectiveness of hæmofiltration in valproic acid intoxication. Acta Pædiatr 2001; 90:958-959.
71. Wasserman GS, Aldridge SC, Kelly JC, Abdel-Rahman SM. A unique valproic acid ingestion. J Toxicol Clin Toxicol 2001; 39:419-422.
72. Brubacher JR, Dahghani P, McKnight D. Delayed toxicity following ingestion of enteric-coated divalproex sodium (Epival). J Emerg Med 1999; 17:463-467.
73. Ingels M, Beauchamp J, Clark RF, Williams SR. Delayed valproic acid toxicity: a retrospective case series. Ann Emerg Med 2002; 39:616-621.
74. LoVecchio F, Thole D, Bagnasco T. Delayed absorption of valproic acid, resulting in coma. Acad Emerg Med 2002; 9:1464.
75. Hintze G, Klein HH, Prange H, Kreuzer H. A case of valproate intoxication with excessive brain edema. Klin Wochenschr 1987; 65:424-427.
76. Ruskosky D, Holmes C, Schauben J. Utilization of hemodialysis to enhance valproic acid (VPA) elimination [abstract]. J Toxicol Clin Toxicol 1999; 37:636-637.
77. Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR. High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 2000; 34: 1146-1151.
78. Neuvonen PJ, Kannisto H, Hirvisalo EL. Effect of activated charcoal on absorption of tolbutamide and valproate in man. Eur J Clin Pharmacol 1983; 24:243-246.
79. Houghton BL, Bowers JB. Valproic acid overdose: a case report and review of therapy. MedGenMed 2003; 5:5.
80. Roberge RJ, Francis EH, 3rd. Use of naloxone in valproic acid overdose: case report and review. J Emerg Med 2002; 22:67-70.
81. Hicks LK, McFarlane PA. Valproic acid overdose and haemodialysis. Nephrol Dial Transplant 2001; 16:1483-1486.
82. Williams SR, Clark RF. Hemodialysis of a valproic acid poisoning [abstract]. J Toxicol Clin Toxicol 1995; 33:491.
83. Drug Facts and comparisons 4.0 [database online]. Wolters Kluwer Health; 2006. URL: http://online.factsandcomparisons.com. Accessed April 2006.
84. Schnabel R, Rambeck B, Janssen F. Fatal intoxication with sodium valproate. Lancet 1984; 1:221-222.
85. Koelliker P, Koelliker D, Toerne T. Bullous skin lesions associated with severe valproic acid overdose in a four year-old child [abstract]. J Toxicol Clin Toxicol 1999; 37:638.